Giuseppina Mariano1, Rebecca J Farthing2, Shamar L M Lale-Farjat2, Julien R C Bergeron2. 1. Microbes in Health and Disease Theme, Newcastle University Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom. 2. Randall Centre for Cell and Molecular Biophysics, King's College London, London, United Kingdom.
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread in humans in almost every country, causing the disease COVID-19. Since the start of the COVID-19 pandemic, research efforts have been strongly directed towards obtaining a full understanding of the biology of the viral infection, in order to develop a vaccine and therapeutic approaches. In particular, structural studies have allowed to comprehend the molecular basis underlying the role of many of the SARS-CoV-2 proteins, and to make rapid progress towards treatment and preventive therapeutics. Despite the great advances that have been provided by these studies, many knowledge gaps on the biology and molecular basis of SARS-CoV-2 infection still remain. Filling these gaps will be the key to tackle this pandemic, through development of effective treatments and specific vaccination strategies.
Severe acute respiratory syndrome coronavirus 2 (n class="Species">SARS-CoV-2) has rapidly spread in humans in almost every country, causing the disease COVID-19. Since the start of the COVID-19 pandemic, research efforts have been strongly directed towards obtaining a full understanding of the biology of the viral infection, in order to develop a vaccine and therapeutic approaches. In particular, structural studies have allowed to comprehend the molecular basis underlying the role of many of the SARS-CoV-2 proteins, and to make rapid progress towards treatment and preventive therapeutics. Despite the great advances that have been provided by these studies, many knowledge gaps on the biology and molecular basis of SARS-CoV-2 infection still remain. Filling these gaps will be the key to tackle this pandemic, through development of effective treatments and specific vaccination strategies.
Authors: Paolo Cravedi; Patrick Ahearn; Lin Wang; Tanuja Yalamarti; Susan Hartzell; Yorg Azzi; Madhav C Menon; Aditya Jain; Marzuq Billah; Marcelo Fernandez-Vina; Howard M Gebel; E Steve Woodle; Natalie S Haddad; Andrea Morrison-Porter; F Eun-Hyung Lee; Ignacio Sanz; Enver Akalin; Alin Girnita; Jonathan S Maltzman Journal: J Am Soc Nephrol Date: 2021-10-01 Impact factor: 10.121
Authors: Rico Ballmann; Sven-Kevin Hotop; Federico Bertoglio; Stephan Steinke; Philip Alexander Heine; M Zeeshan Chaudhry; Dieter Jahn; Boas Pucker; Fausto Baldanti; Antonio Piralla; Maren Schubert; Luka Čičin-Šain; Mark Brönstrup; Michael Hust; Stefan Dübel Journal: Viruses Date: 2022-06-17 Impact factor: 5.818